Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: Case reports and review of the literature

Pituitary

Volumn 15, Issue 1 SUPPL., 2012, Pages

  Shah, Reshma ^a   Licata, Angelo ^b   Oyesiku, Nelson M ^a   Ioachimescu, Adriana G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acromegaly; Growth hormone; Hypercalcemia; Insulin like growth factor 1; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ANGIOPEPTIN; CALCITRIOL; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; GLIPIZIDE; GROWTH HORMONE; METFORMIN; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHORUS; SITAGLIPTIN; SOMATOMEDIN C; VITAMIN D; 1,25-DIHYDROXYVITAMIN D; DRUG DERIVATIVE; HUMAN GROWTH HORMONE;

ACROMEGALY; ADRENAL FUNCTION; ADULT; ALBUMIN BLOOD LEVEL; BREAST SURGERY; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CANCER RADIOTHERAPY; CARPAL TUNNEL SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ELECTIVE SURGERY; ENZYME BLOOD LEVEL; FATIGUE; FEMALE; HEADACHE; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; HYPERCALCEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; KIDNEY FUNCTION; LIBIDO DISORDER; MEDICAL HISTORY; NEPHROLITHIASIS; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; STEREOTACTIC PROCEDURE; THYROID FUNCTION; TRANSSPHENOIDAL ADENECTOMY; TRANSSPHENOIDAL SURGERY; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL FIELD DEFECT; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; METABOLISM; MIDDLE AGED;

ACROMEGALY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPERCALCEMIA; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; VITAMIN D;

EID: 84871951676     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-010-0286-8     Document Type: Review

References (35)

1. Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR (1993) Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76(6):1452-1457
2. Hennessey JV, Jackson IM (1995) Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly. Baillieres Clin Endocrinol Metab 9(2):271-314
3. Lund B, Eskildsen PC, Norman AW, Sorensen OH (1981) Calcium and vitamin D metabolism in acromegaly. Acta Endocrinol (Copenh) 96(4):444-450
4. Takamoto S, Tsuchiya H, Onishi T, Morimoto S, Imanaka S, Mori S, Seino Y, Uozumi T, Kumahara Y (1985) Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy. J Clin Endocrinol Metab 61(1):7-11
5. Brown J, Singer FR (1969) Calcium metabolism in acromegaly. Br Med J 2(5648):50
6. Yamamoto T (1988) A case of active acromegaly with reduced height and type 1 renal tubular acidosis. Endocrinol Jpn 35(1):165-170
7. Sigurdsson G, Nunziata V, Reiner M, Nadarajah A, Joplin GF (1973) Calcium absorption and excretion in the gut in acromegaly. Clin Endocrinol (Oxf) 2(3):187-192
8. Ben-Shlomo A, Melmed S (2008) Acromegaly. Endocrinol Metab Clin North Am 37(1):101-122. doi: 10.1016/j.ecl.2007.10.002
9. Ioachimescu AG, Bauer TW, Licata A (2008) Active crohn disease and hypercalcemia treated with infliximab: case report and literature review. Endocr Pract 14(1):87-92. doi: W782084N30434158
10. Jacobs TP, Bilezikian JP (2005) Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab 90(11):6316-6322. doi: 10.1210/jc.2005-0675
11. Khan A, Bilezikian J (2000) Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163(2):184-187
12. Kallas M, Green F, Hewison M, White C, Kline G (2010) Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 95(7):3111-3117. doi: 10.1210/jc.2009-2673
13. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE (1979) Evaluation of acromegaly by radioimmunoassay of somatomedin-c. N Engl J Med 301(21):1138-1142. doi: 10.1056/NEJM197911223012102
14. Puder JJ, Nilavar S, Post KD, Freda PU (2005) Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. J Clin Endocrinol Metab 90(4):1972-1978. doi: 10.1210/jc.2004-2009
15. Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ (2003) Pegvisomant-induced serum insulin-like growth factor-i normalization in patients with acromegaly returns elevated markers of bone turnover to normal. J Clin Endocrinol Metab 88(12):5650-5655
16. Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM (1990) Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70(2):519-527
17. Bianda T, Hussain MA, Glatz Y, Bouillon R, Froesch ER, Schmid C (1997) Effects of short-term insulin-like growth factor-i or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin d3 production in healthy man. J Intern Med 241(2):143-150
18. Bianda T, Glatz Y, Bouillon R, Froesch ER, Schmid C (1998) Effects of short-term insulin-like growth factor-i (igf-i) or growth hormone (gh) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in gh-deficient adults. J Clin Endocrinol Metab 83(1):81-87
19. Pavlovitch H, Fontaine O, Balsan S (1978) Effect of growth hormone on the metabolism of 25-hydroxycholecalciferol in hypophysectomized rats on a diet without vitamin D and low in calcium. J Endocrinol 79(3):277-281
20. Spencer EM, Tobiassen O (1981) The mechanism of the action of growth hormone on vitamin D metabolism in the rat. Endocrinology 108(3):1064-1070
21. Wongsurawat N, Armbrecht HJ, Zenser TV, Forte LR, Davis BB (1984) Effects of hypophysectomy and growth hormone treatment on renal hydroxylation of 25-hydroxycholecalciferol in rats. J Endocrinol 101(3):333-338
22. White HD, Ahmad AM, Durham BH, Chandran S, Patwala A, Fraser WD, Vora JP (2006) Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity. J Clin Endocrinol Metab 91(3):913-919. doi: 10.1210/jc.2005-1602
23. Brown DJ, Spanos E, MacIntyre I (1980) Role of pituitary hormones in regulating renal vitamin D metabolism in man. Br Med J 280(6210):277-278
24. Cappelli C, Gandossi E, Agosti B, Cerudelli B, Cumetti D, Castellano M, Pirola I, De Martino E, Rosei EA (2004) Long-term treatment of acromegaly with lanreotide: evidence of increased serum parathormone concentration. Endocr J 51(6):517-520. doi: JST.JSTAGE/endocrj/51.517
25. Fredstorp L, Pernow Y, Werner S (1993) The short and long-term effects of octreotide on calcium homeostasis in patients with acromegaly. Clin Endocrinol (Oxf) 39(3):331-336
26. Lancer SR, Bowser EN, Hargis GK (1976) The effect of growth hormone on parathyroid function in rats. Endocrinology 98(5):1289-1293
27. Ben-Shlomo A, Melmed S (2006) Skin manifestations in acromegaly. Clin Dermatol 24(4):256-259. doi: 10.1016/j.clindermatol.2006.04.011
28. Bogh MK, Schmedes AV, Philipsen PA, Thieden E, Wulf HC (2010) Interdependence between body surface area and uvb dose in vitamin D production: A randomized controlled trial. Br J Dermatol. doi: 10.1111/j.1365-2133.2010. 10082.x
29. Ardawi MS, Nasrat HA HSBAA (1997) Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur J Endocrinol 137(4):402-409
30. Prentice A (2000) Calcium in pregnancy and lactation. Annu Rev Nutr 20:249-272. doi: 10.1146/annurev.nutr.20.1.24920/1/249
31. Hosking DJ (1996) Calcium homeostasis in pregnancy. Clin Endocrinol (Oxf) 45(1):1-6
32. Ajibade DV, Dhawan P, Fechner AJ, Meyer MB, Pike JW, Christakos S (2010) Evidence for a role of prolactin in calcium homeostasis: regulation of intestinal transient receptor potential vanilloid type 6, intestinal calcium absorption, and the 25-hydroxyvitamin d(3) 1alpha hydroxylase gene by prolactin. Endocrinology 151(7):2974-2984. doi: 10.1210/en.2010-0033
33. Bikle DD, Spencer EM, Burke WH, Rost CR (1980) Prolactin but not growth hormone stimulates 1, 25-dihydroxyvitamin d3 production by chick renal preparations in vitro. Endocrinology 107(1):81-84
34. Kovacs CS, Fuleihan Gel H (2006) Calcium and bone disorders during pregnancy and lactation. Endocrinol Metab Clin North Am 35(1):21-51. doi: 10.1016/j.ecl.2005.09.004
35. Kumar R, Abboud CF, Riggs BL (1980) The effect of elevated prolactin levels on plasma 1, 25-dihydroxyvitamin d and intestinal absorption of calcium. Mayo Clin Proc 55(1):51-53